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Intrinsically disordered regions are present in one-third of
eukaryotic proteins and are overrepresented in cellular pro-
cesses such as signaling, suggesting that intrinsically disordered
proteins (IDPs) may have a functional advantage over folded
proteins. Upon interacting with a partner macromolecule, a
subset of IDPs can fold and bind to form a well-defined three-
dimensional conformation. For example, disordered BH3-only
proteins bind promiscuously to a large number of homologous
BCL-2 family proteins, where they fold to a helical structure in a
groove on theBCL-2–like protein surface.As twoprotein chains
are involved in the folding reaction, and the structure is only
formed in thepresence of thepartnermacromolecule, this raises
the question of where the folding information is encoded. Here,
we examine these coupled folding and binding reactions to
determine which component determines the folding and bind-
ing pathway. Using value analysis to compare transition state
interactions between the disordered BH3-only proteins PUMA
and BID and the folded BCL-2–like proteins A1 andMCL-1, we
found that, even though the BH3-only protein is disordered in
isolation and requires a stabilizing partner to fold, its folding
and binding pathway is encoded in the IDP itself; the reaction is
not templated by the folded partner.We suggest that, by encod-
ing both its transition state and level of residual structure, an
IDP can evolve a specific kinetic profile, which could be a crucial
functional advantage of disorder.
Folded proteins contain a plethora of information; three-di-
mensional conformations, folding pathways, (un)folding rates,
stability, and function are all encoded within the amino acid
chain (1). Unlike their folded counterparts, the primary
sequences of intrinsically disordered proteins (IDPs)5 encode a
lack of well-defined three-dimensional structure (2). Instead,
they exist as an ensemble of conformations. When binding to a
partner macromolecule, a subset of IDPs can transition from
this conformational ensemble to a stable, well-defined struc-
ture (3, 4). Final conformations of IDPs in these folding-upon-
binding reactions can differ depending on the partner protein.
For example, the disordered C-terminal domain of p53 can fold
and bind as a strand (5), a helix (6), or a coil (7) when interacting
with Sir2, S100B(), and cyclin A, respectively. In other cases,
an IDP can form essentially the same structure when it binds
promiscuously to a number of different partners, as when dis-
ordered BH3-only proteins bind to BCL-2 family proteins to
form a single helix (8). The bound conformation may be tran-
siently sampled by the free IDP but only becomes significantly
populated in the presence of the stabilizing partner macromol-
ecule. There are two extreme possibilities for the folding of the
IDP in this situation. Either the IDP could encode the folding
pathway (that is, determine the order of events), or the reaction
could be templated by the partner protein (9).
Value analysis is amethod that probes the folding pathway
by comparing the interactions a residue makes in the reaction
transition state and the final, bound state (10). This is achieved
through shortening the side chain of the amino acid, thus delet-
ing contacts formed, andmonitoring the impact on the stability
and kinetics of the reaction. Thismethod has been a useful tool,
enabling the folding of families of homologous (well-folded)
proteins to be compared (11), and it has also been used to inves-
tigate IDP–protein interactions (12–19).We previously used
value analysis to investigate the interaction between the intrin-
sically disordered BH3-only protein PUMA and the folded
BCL-2–like protein MCL-1 (12). Here we investigate the
binding of PUMA to A1, another folded BCL-2–like protein,
and show that the pathway for folding and binding is con-
served. Based on this observation, we hypothesized that the
folding and binding pathway is encoded within the IDP
sequence, and we performed a  value analysis for BID,
another disordered BH3-only protein, when folding and
binding to A1 and MCL-1 to test our assumptions. As pre-
dicted, BID displayed a conserved pattern of  values when
binding to A1 and MCL-1, which differed from the pattern
observed for PUMA. We therefore conclude that the folding
and binding pathways for intrinsically disordered BH3-only
proteins are encoded within the sequence of the IDP, not
templated by the partner protein.
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Comparison ofMCL-1 and A1
We have shown previously that PUMA has a relatively early
transition state when folding and binding to MCL-1, with few
inter- or intramolecular interactions formed (12). Residues
toward the N terminus of PUMA display slightly higher  val-
ues, indicating that weak structure formation in this region sta-
bilizes the transition state. To determine whether these transi-
tion state interactions are templated by the partner protein, we
investigated the interaction of PUMA with A1, another folded
BCL-2–like protein. Upon binding A1, PUMA folds into a sin-
gle contiguous -helix, forming a structure that closely resem-
bles that of PUMA bound to MCL-1 (Fig. 1). Although the
bound conformations are homologous, sequence alignment of
the MCL-1 and A1 constructs showed that they share a total
sequence identity of only 26% (Fig. 1 and Fig. S1A). Further
analysis of the structures of PUMA bound to MCL-1 (20) and
A1 (21) indicated that the binding interface shared a greater
degree of identity (52%) because of a conserved seven-residue
stretch (NWGRIVT). Six of these residues (NWGRVT) make
contact with the C-terminal region of PUMA (Fig. 2 and Fig.
S2). Importantly, the N-terminal region of PUMA, which had
the highest  values when binding MCL-1 (12), contacts resi-
dueswith different chemical properties inA1. Furthermore, the
presence of Glu-78 and Glu-80 in A1 (Val-234 and Lys-236 in
MCL-1) (Fig. S3) introduces a negative charge into the binding
grove (21), whereas the electrostatic potential of the MCL-1
grove is positive (22). A1 therefore provides a good comparison
with MCL-1, as PUMA folds to the same structure, but in the
presence of different stabilizing amino acids with different
physiochemical properties. If it were the binding partner that
templates the folding pathway, then we might expect the pat-
tern of  values to be different for PUMA binding to A1 and
MCL-1.
The folding pathway for the IDP PUMA is conservedwhen
binding to different partners
As for the previous  value analysis (12), PUMA mutations
were chosen that probed both the interfacial contacts and the
amount of helicity in the reaction transition state (Fig. 3A).
Bindingwasmonitored by following the change in fluorescence
of TAMRA, a fluorescent dye that was conjugated to the N
terminus of PUMA, upon binding to A1 (Fig. S4). Ten of the 12
mutations resulted in a change in Gibbs free energy of binding
of 0.6 kcal mol1 (Fig. 3B), which is typically considered the
minimum required to calculate  values (23). Analysis of all
alanine and glycine mutants demonstrated that changes in koff,
rather than kon, were predominantly responsible for differences
in binding affinity (Fig. 3C and Table S1). From the linear free
energy plot, the gradient of ln(kon) versus ln(Kd) provided a
Leffler value of 0.18 0.04, indicating that the transition state
Figure 1. Structural homology and sequence identity of complexes between BH3-only and BCL-2–like proteins. The IDPs PUMA (blue) and BID (yellow)
fold to a single contiguous -helix upon binding either the folded partner protein MCL-1 (gray) or A1 (green). Sequence identities were produced from
alignments of mouse protein constructs. Rootmean square deviation (RMSD) values were obtained from backbone atom structural alignments using PyMOL.
N indicates the N terminus of each protein.
Figure 2. The N-terminal region of PUMA contacts residues with differ-
ent chemical properties when bound to MCL-1 and A1. The bound struc-
ture of PUMA and noncontacting residues inMCL-1 and A1 are shown in light
gray. Residues that contact PUMAwere determined using PyMOL (PDB codes
2ROC and 2VOF), assuming the minimal cutoff (0.001 Å2) to account for all
possible contacts between PUMA and its partners. Contacting residues are
highlighted in thebound structure according to their conservationas follows:
identical residues in red, similar in orange (e.g. both hydrophobic, same
charges), and different in blue (e.g. opposite charges; one hydrophobic, one
polar) (determined from the alignment of theMCL-1 andA1 sequences using
Clustal Omega (32, 33)).
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was structurally early. However, although this gives a global
picture of the interactions formed in the transition state that is
similar to PUMA binding MCL-1 (  0.1  0.04) (12), it can
hide the detail provided by a residue-level technique such as
value analysis. We therefore employed this method to deter-
mine which PUMA residues were forming interactions with A1
in the transition state. A remarkable similarity in  values was
observed for PUMA binding A1 and PUMA binding MCL-1
(Fig. 3D). Both the pattern of higher values at the N terminus
and the absolute values were conserved when binding to either
partner protein.
Choice ofmutations for the IDP BID
The resemblance of the reaction transition states indicated
that the folding and binding pathway is encoded within the IDP
(PUMA). To test the generality of this hypothesis, we investi-
gated the binding of BID to A1 and MCL-1. The BH3-only
region of BID is another intrinsically disordered protein (Fig.
S5) that folds upon binding, forming a structure that is homo-
logous to bound PUMA (Fig. 1). Because of the low sequence
identity between BID and PUMA (14%) (Fig. S1B), the values
for BID should differ to those observed for PUMA if the IDP
encodes the folding and binding pathway. BID residues that
matched the position of the probed residues in PUMA were
chosen for analysis. Five of the interface mutations (Fig. 4A)
destabilized the complex with both A1 and MCL-1 by more
than 0.6 kcal mol1 (Tables S2 and S3) and were used to deter-
mine values.Mutations designed to probe the transition state
helicity of BIDdid not achieve this destabilization cutoff in both
A1 and MCL-1 (Tables S2 and S3). A comparative analysis of
the transition states of BID binding to A1 and MCL-1 was
therefore produced using only interface  values.
The folding and binding pathway is encodedwithin the IDP
All of the calculated interface values were low (0.2), indi-
cating that few interactions were formed in the transition state.
Unlike PUMA, which had higher  values at the N terminus,
the pattern for BID indicated that interface interactions in the
central section were stabilizing the transition state (Fig. 4B).
The distinct pattern was replicated for BID binding to both A1
andMCL-1, supporting the original hypothesis that the transi-
tion state is encoded within the sequence of the IDP.When the
data for both IDPs were combined, correlation of the  values
obtained for the IDP with each partner protein (Fig. 4C) illus-
trated that the folding and binding information was contained
within the IDP, not the partner protein (Fig. S6).
Discussion
IDPs are typically overrepresented in cell signaling (24), a
process that can comprise complex networks of many protein
partners. The BCL-2 family is a model system for folding and
binding reactions at the heart of these signaling networks. For
example, PUMA and BID are disordered BH3-only proteins
Figure 3. Mutations to the IDP PUMA predominantly alter the affinity for A1 through modulating koff. A, the position of PUMA (blue) mutations are
indicated in orange. Mutations were either designed to probe interface interactions (sticks) with A1 (green) through shortening the side chain to alanine or
intramolecular helicity (spheres) via alanine-to-glycinemutations. TheN terminus of PUMA is shown on the left. B, binding destabilization upon probing PUMA
interface interactions and helicity by mutation. C, linear free energy plot showing kon (open circles) and koff (filled circles) against Kd for every PUMA mutant
binding A1. Kd values were calculated from the ratio of the kinetic rate constants (koff/kon), as the affinity was generally too tight (1 nM) to measure using
equilibrium binding experiments. Some mutations shifted the affinity to a regime that could be measured at equilibrium (Fig. S7). In these cases, the
determined Kd values compared well with the values calculated from the ratio of the rate constants (Table S4). D, comparison of values obtained for PUMA
binding to its folded partners, A1 and MCL-1. Error bars represent propagated errors.
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that can fold upon binding and initiate apoptosis through inter-
acting with multiple partner proteins (25, 26).
Although value analysis has been extensively used to char-
acterize the folding pathway andmechanismof folded proteins,
only a handful have been performedonother IDP-coupled fold-
ing and binding systems (12–19). Generally, these have demon-
strated transition states that occur early along reaction coordi-
nates, with few interactions formed (12–16). Our data for
disordered BH3-only proteins binding BCL-2–like partners are
consistent with this view of relatively unstructured transition
states for IDPs that fold to simple conformations upon binding.
The N-terminal region of PUMA displays higher  values
than the C-terminal end when binding to MCL-1, indicating
that this region is important in stabilizing the reaction tran-
sition state (12). Given that IDPs can fold to different structures
upon interacting with different partner proteins (5–7), it is easy
to assume that the partner templates the folding reaction (9). If
this is the case, then changing the partner protein to which
PUMA should alter the transition state interactions. We there-
fore chose to investigate the binding of PUMA to a partner
protein that had different interactions at the N terminus of
PUMA and altered physiochemical properties of the binding
groove (21, 22). In contrast to the templating hypothesis, we
found that the transition state remained unchanged, indicating
that the IDP (PUMA) encodes its transition state. This conclu-
sionwas supported by a value analysis of the disordered BH3-
only protein BID, which displayed a different pattern of value
than PUMA that was replicated when binding to either MCL-1
or A1. Interestingly, simulations of the unbound structure of
PUMA indicate that it displays a greater degree of helicity
toward the N terminus (27), whereas the CD analysis in this
work indicated that BID is largely disordered when unbound.
This is consistent with both transition states; PUMA has a
slightly later transition state with higher  values at the N ter-
minus, perhaps suggesting that the unbound structure of the
IDP has an influence on the transition state interactions.
IDPs have the potential to encode both their level of residual
structure and, as we show here, the structure of the transition
states for coupled folding and binding; this provides an oppor-
tunity to evolve specific kinetic profiles. This could be of crucial
importance in cell signaling processes, where disorder is con-
served and abundant (24, 28), as responses to stimuli may have
to occur quickly (e.g. activation of a cell surface receptor), or
may need to be decisive and relatively irreversible (e.g. stimula-
tion of apoptosis). Changing the residual structure or encoded
transition state provides an accessible method for evolution to
tune the lifetimes of these complexes, which may be one expla-
nation for the evolutionary conservation of disorder.
Experimental procedures
Buffers
All biophysical experiments were carried out in 50 mM
sodium phosphate, 0.05% (v/v) Tween 20 (pH 7.0).
Proteins and peptides
BID (mouse, residues 76–110, UniProt P70444) and PUMA
(mouse, residues 127–161, UniProt Q99ML1) peptides were
synthesized by Biomatik. To reduce the oligomerization pro-
Figure 4. The folding and binding pathway is encoded within the IDP rather than the stabilizing partner. A, interface residues (sticks) in comparable
helical turns were investigated for both the IDPs, PUMA (blue), and BID (yellow). The N terminus of each peptide is shown on the left. B, comparison of the
values obtained for the interface residues in BID (top panel) and PUMA (bottom panel) when binding to either A1 or MCL-1. C, correlation of values obtained
for the IDPwhenbinding toMCL-1 andA1. Togetherwith the IDP interfacedata, the values fromhelix-probingmutations in PUMA that destabilizedboth the
A1 and MCL-1 complex by0.6 kcal mol1 are included in the correlation plot. Error bars represent the propagated errors.
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pensity, WT PUMA contained an M144A mutation, as
described previously (29). A fluorescent dye, 5-carboxytetram-
ethylrhodamine (TAMRA), was conjugated at the N terminus.
The peptides were reconstituted in biophysical buffer and fil-
tered (0.22 m). Stock solutions were frozen in liquid N2 and
stored at 80 °C. Expression and purification protocols for
recombinantly produced MCL-1 (mouse, 152–308 residues,
UniProt P97287), A1 (mouse, residues 1–152, UniProt
Q07440), and PUMA are described in the supplemental Exper-
imental Procedures.
Circular dichroism
CD scans were acquired in an Applied Photophysics Chiras-
can using 1 cm (for PUMA) and 2 mm (for BID) path length
cuvettes. Estimates for percentage helicity were calculated
using the mean ellipticity at 222 nm and the method of Muñoz
and Serrano (30). Scans were performed at multiple concentra-
tions to check for the presence of oligomers (PUMA, 0.25–1
M; BID, 5 and 10 M).
Binding kinetics
Association kinetics were monitored using SX18 and SX20
fluorescence stopped-flow spectrometers (Applied Photophys-
ics) by following the TAMRA dye fluorescence, with excitation
at 555 nm and emission recorded above 570 nm. Experiments
were done at 25 °C, and a minimum of 15 fluorescence traces
were collected and averaged before analysis. Data collected
before the deadtime of mixing (1 ms) were removed. Pseudo-
first-order conditions were adopted, with the concentration of
the folded partner at least 10-fold higher than that of the pep-
tide (31). For each peptide concentration, the traces were aver-
aged and fit to a single exponential equation to extract the
observed rate constant (kobs) of reaching the new equilibrium.
The gradient from the straight line fit of kobs versus the concen-
tration of partner protein was used to determine kon.
Dissociation kinetics were monitored either using Applied
Photophysics SX18 and SX20 stopped-flow spectrometers (kobs
 0.03 s1) or a VarianCary Eclipse spectrophotometer (kobs
0.03 s1) at 25 °C. A preformed complex of peptide and partner
protein (PUMA–A1, BID–MCL-1, and BID–A1) was mixed
with various concentrations of unlabeled PUMA peptide (used
as a competitor). The change in fluorescence upon formation of
the new equilibriumwasmonitored and fit to a single exponen-
tial function to determine kobs. With sufficient excess of the
competitor, kobs represents koff, and the concentration indepen-
dent rate constants were averaged to ascertain koff.
Equilibrium binding
Equilibrium dissociation constants (Kd) were measured at
25 °C by fluorescence anisotropy using a Cary Eclipse spectro-
photometer (Varian). The TAMRA fluorophore was excited at
555 nm, and the emission was recorded at 575 nm. A detailed
description of the data analysis used to extract the Kd is
included in the supplemental Experimental procedures.
Data analysis
Data were analyzed using Kaleidagraph. The figures were
prepared using Kaleidagraph and PyMOL. Errors were propa-
gated using standard methods.
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